The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Raising the level of cancer care: Feasibility and reported benefit of a virtual tumor board.
 
Lauren Chiec
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Precisca
 
Naomi Dempsey
Employment - Baptist Health South Florida
Consulting or Advisory Role - Daiichi Sankyo; MJH Life Sciences
Travel, Accommodations, Expenses - Precisca
 
Mohit Shiv Agarwal
Consulting or Advisory Role - Precisca
 
John R Ogden
Consulting or Advisory Role - PrecisCa
 
James R. Broughman
No Relationships to Disclose
 
Zachary Mayo
Consulting or Advisory Role - Precisca
 
Erin Shonkwiler
Consulting or Advisory Role - Precisca
 
Michael Chaby
No Relationships to Disclose
 
Mark A. Socinski
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Lilly; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech; Janssen; Lilly; Novartis
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; G1 Therapeutics; Genentech; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Spectrum Pharmaceuticals (Inst)
 
Mark D. Pegram
Honoraria - Genentech/Roche; Pfizer; Seagen
Consulting or Advisory Role - Genentech/Roche; Pfizer; Seagen
 
Mehmet Asim Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; Seagen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - HalioDx (Inst); Ipsen (Inst); Pfizer (Inst)
Research Funding - Merck (Inst)
 
Reni Butler
No Relationships to Disclose
 
Michael J. Thirman
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; Celgene; Genentech; Pharmacyclics
Research Funding - Abbvie (Inst); Merck (Inst); Syndax (Inst); TG Therapeutics (Inst)
 
William John Gradishar
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Genentech/Roche; merck; Pfizer; Puma Biotechnology; Seagen
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Benjamin Philip Levy
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Turning Point Therapeutics (Inst)
 
Alexandra Drakaki
Employment - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I); Dyania Health (I)
Leadership - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I)
Stock and Other Ownership Interests - Alimera Sciences (I); Athos Therapeutics (I); ATTICA SCIENCES; Dyania Health (I); Kyn therapeutics (I); Moderna Therapeutics (I); PROTEAS BIOANALYTICS (I); Urogen pharma (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; DYANIA HEALTH; Exelixis; Janssen; Merck; PACT Pharma; RADMETRIX; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); BMS (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Kite/Gilead; Merck Sharp & Dohme (Inst); Seattle Genetics/Astellas (Inst)
Patents, Royalties, Other Intellectual Property - My significant other has several patents with UCLA, Harvard Medical School, Athos Therapeutics, Proteas Bioanalytics and ATTICA Sciences (I)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Seagen
 
Susan F. Slovin
Consulting or Advisory Role - Bayer; Clovis Oncology; Pfizer
Speakers' Bureau - OncLive; PER; Prime Oncology; Society for Immunotherapy of Cancer
Research Funding - AstraZeneca
 
Mohammad Jahanzeb
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Immunomedics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Seagen; Takeda
Speakers' Bureau - AstraZeneca; Immunomedics; Merck; Novartis; Pfizer; Seagen
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Callisto Pharmaceuticals (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Immunomedics; Merck; Novartis; takeda